Multiple myeloma: Lenalidomide in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma.
Lenalidomide as monotherapy is indicated for maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous hematopoietic stem cell transplantation (Auto-HSCT).